Market closed

Zoetis/ZTS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Zoetis

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Ticker

ZTS

Trading on

NYSE

Industry

Pharmaceuticals

Employees

14,100

Zoetis Metrics

BasicAdvanced
$87B
Market cap
37.46
P/E ratio
$5.10
EPS
0.88
Beta
$1.67
Dividend rate
0.90%
Dividend yield
$87B
0.88
$201.92
$144.80
1.8M
$1.67
3.451
1.646
136.573
136.573
31.57%
13.69%
14.41%
48.89%
37.461
9.816
17.45
86.59
41.61
0.87%
0.90%
8.43%
7.42%
6.35%
8.52%
21.49%

What the Analysts think about Zoetis

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Zoetis stock.

Zoetis Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Zoetis Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy ZTS

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Zoetis stock?

Zoetis (ZTS) has a market cap of $87B as of October 05, 2024.

What is the P/E ratio for Zoetis stock?

The price to earnings (P/E) ratio for Zoetis (ZTS) stock is 37.46 as of October 05, 2024.

Does Zoetis stock pay dividends?

Yes, the Zoetis (ZTS) stock pays dividends to shareholders. As of October 05, 2024, the dividend rate is $1.671 and the yield is 0.9%. Zoetis has a payout ratio of 31.57% on a trailing twelve-month basis.

When is the next Zoetis dividend payment date?

The next Zoetis (ZTS) dividend payment date is unconfirmed.

What is the beta indicator for Zoetis?

Zoetis (ZTS) has a beta rating of 0.88. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.